Why the study?
Is increased Superoxide Dismutase Copper/Zinc Type activity associated with adverse outcomes in patients with Coronary Artery Disease?
Is increased Superoxide Dismutase Copper/Zinc Type activity associated with adverse outcomes in patients with Coronary Artery Disease?
Increased superoxide dismutase copper/zinc type activity may serve as a prognostic marker for adverse outcomes in patients with coronary artery disease.
Answers are grounded in this paper and cite their sources.
May flag higher-risk CAD patients; leaves open SOD activity as a validated prognostic marker pending prospective studies.
Increased SOD activity beyond the normal range in the human physiology is related to an adverse outcome in patients with CAD.
No takes yet. Share an insight, caveat, or question.
Zengin et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: